ArticlePloS one2026
Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.
Paula Marcus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it